Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR... Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. Show more
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that management will participate in the following...
On track to present additional clinical data from the RUBY trial and the EdiTHAL trial by year-end In vivo preclinical proof-of-concept for an undisclosed indication on-track by year-end Strong...
CAMBRIDGE, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that it will host a conference call and webcast...
All patients treated in the RUBY trial are free of vaso-occlusive events post-renizgamglogene autogedtemcel (reni-cel) infusion Patients had early normalization of total hemoglobin with a mean...
All patients treated in the EdiTHAL trial maintained hemoglobin levels above the transfusion threshold and are transfusion-free post-renizgamglogene autogedtemcel (reni-cel) infusion Reni-cel was...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 4.48548812665 | 3.79 | 4.12 | 3.635 | 2036560 | 3.86077215 | CS |
4 | -0.12 | -2.94117647059 | 4.08 | 4.12 | 3.4 | 1673721 | 3.7351873 | CS |
12 | -0.87 | -18.0124223602 | 4.83 | 6.05 | 3.4 | 1651351 | 4.46381401 | CS |
26 | -3.72 | -48.4375 | 7.68 | 8.44 | 3.4 | 1862684 | 5.25569873 | CS |
52 | -4.05 | -50.5617977528 | 8.01 | 11.69 | 3.4 | 1875510 | 7.01914228 | CS |
156 | -56.3 | -93.4284766014 | 60.26 | 62.4 | 3.4 | 1787332 | 12.4161432 | CS |
260 | -21.28 | -84.3106180666 | 25.24 | 99.95 | 3.4 | 1629192 | 23.51112642 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.